Clinical trials for cancer are regulated by various national and international bodies to ensure the safety and rights of participants are protected. In the United States, the FDA is the primary regulatory authority. In Europe, the EMA plays a similar role. These agencies establish guidelines that researchers must follow, including obtaining ethical approval, ensuring informed consent, and reporting adverse events.
